30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Fidia's HYMOVIS Receives Product-Specific J-Code -

The U.S. Center for Medicare & Medicaid Services (CMS) assigned a unique Healthcare Common Procedure Coding System (HCPCS) code or J-Code to Fidia Pharma's HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. The reimbursement code is effective January 2017.

The product was launched in the U.S. at AAOS 2016.

Other viscosupplements in 2016 news include:



Sources: Fidia Pharma USA Inc.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.